Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07619391 · ClinicalTrials.gov registry record · NA
MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT07619391 is a NA study that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 30 participants.
The verdict
NCT07619391, a NA study, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This clinical trial tests the feasibility of using the MyCap mobile application (app) for tracking time burden from treatment for patients with pancreatic cancer. Pancreatic cancer is best treated with many care teams, such as medical oncology and surgery, requiring patients to dedicate significant time coordinating appointments among different doctors. This time commitment is referred to as time toxicity, defined as the time spent undergoing cancer-related medical care, such as emergency visits, ambulatory care, lab and infusion visits, hospitalizations, and the commuting and waiting times associated with each. At present, time toxicity is still understudied within the medical literature, with no gold standard established for the method of measurement. The MyCap mobile app may be a feasible way to track the time burden from treatment for patients with pancreatic cancer.
Interventions
- OTHER Survey Administration
- OTHER Electronic Health Record Review
- BEHAVIORAL Smartphone Application-based Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-03-10 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07619391
The ClinicalTrials.gov registry entry for NCT07619391 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Survey Administration is the first listed.
NCT07619391 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07619391 about?
NCT07619391 is a clinical study titled "MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer". This clinical trial tests the feasibility of using the MyCap mobile application (app) for tracking time burden from treatment for patients with pancreatic cancer. Pancreatic cancer is best treated with many care teams, such as medical oncology and surgery, requiring patients to dedicate significant ...
What is the current status of trial NCT07619391?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-03-10. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT07619391?
The interventions under investigation include: Survey Administration (OTHER), Electronic Health Record Review (OTHER), Smartphone Application-based Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07619391?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.